Maven Securities LTD Exagen Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.12 - $11.06 $373,735 - $580,550	-52,491 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.97 - $14.08 $897,125 - $1.41 Million	-100,014 Reduced 65.58%	52,491 $610,000
Q3 2021 Nov 15, 2021	SELL	$10.25 - $15.21 $116,932 - $173,515	-11,408 Reduced 6.96%	152,505 $2.07 Million
Q2 2021 Aug 16, 2021	SELL	$12.4 - $17.92 $137,478 - $198,679	-11,087 Reduced 6.34%	163,913 $2.47 Million
Q1 2021 May 17, 2021	BUY	$13.9 - $22.0 $2.43 Million - $3.85 Million	175,000 New	175,000 $3.04 Million

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.